NDRG2

NDRG family member 2, the group of MicroRNA protein coding host genes|NDRG family

Basic information

Region (hg38): 14:21016763-21070872

Links

ENSG00000165795NCBI:57447OMIM:605272HGNC:14460Uniprot:Q9UN36AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NDRG2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDRG2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
15
clinvar
1
clinvar
1
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 15 1 2

Variants in NDRG2

This is a list of pathogenic ClinVar variants found in the NDRG2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-21017625-G-A not specified Uncertain significance (Sep 17, 2021)2319800
14-21017625-G-T not specified Uncertain significance (Apr 23, 2024)3298985
14-21017636-G-A not specified Uncertain significance (Feb 05, 2024)3186240
14-21017687-T-C not specified Uncertain significance (Aug 14, 2024)3403760
14-21018034-C-T not specified Uncertain significance (Jul 14, 2021)2382293
14-21018512-A-G Benign (Mar 01, 2018)773852
14-21018786-G-T not specified Uncertain significance (Nov 19, 2024)3403757
14-21019117-T-C not specified Uncertain significance (May 26, 2022)2396243
14-21019138-G-A not specified Uncertain significance (Mar 31, 2024)3298986
14-21019158-C-A not specified Uncertain significance (Jan 24, 2024)3186281
14-21019687-T-C not specified Uncertain significance (Nov 07, 2022)2322801
14-21019696-A-G not specified Uncertain significance (Jul 02, 2024)3403759
14-21019700-T-G not specified Uncertain significance (Jun 27, 2022)3186273
14-21019714-A-G not specified Uncertain significance (Jan 10, 2023)3186269
14-21019720-T-C not specified Uncertain significance (May 06, 2024)3298984
14-21020500-T-C not specified Uncertain significance (May 24, 2023)2551071
14-21020798-G-C not specified Uncertain significance (Oct 20, 2023)3186261
14-21020837-T-C not specified Uncertain significance (Jul 12, 2023)2593065
14-21021833-C-T not specified Likely benign (Aug 16, 2021)2382925
14-21021844-A-G not specified Uncertain significance (Sep 10, 2024)2391061
14-21022081-C-G not specified Uncertain significance (Oct 29, 2024)3403762
14-21022102-C-A not specified Uncertain significance (Sep 18, 2023)3186251
14-21022150-C-T not specified Uncertain significance (May 10, 2024)3298987
14-21022423-C-A Benign (May 04, 2018)723324
14-21022431-G-A not specified Uncertain significance (Oct 08, 2024)3403761

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NDRG2protein_codingprotein_codingENST00000556147 1554110
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00002200.9961257300181257480.0000716
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6211922180.8820.00001222387
Missense in Polyphen6999.260.695151030
Synonymous-0.2968985.51.040.00000508737
Loss of Function2.521225.80.4650.00000126288

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009060.0000905
Ashkenazi Jewish0.00009970.0000992
East Asian0.00005890.0000544
Finnish0.0001390.000139
European (Non-Finnish)0.00008820.0000879
Middle Eastern0.00005890.0000544
South Asian0.00003290.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Contributes to the regulation of the Wnt signaling pathway. Down-regulates CTNNB1-mediated transcriptional activation of target genes, such as CCND1, and may thereby act as tumor suppressor. May be involved in dendritic cell and neuron differentiation. {ECO:0000269|PubMed:12845671, ECO:0000269|PubMed:16103061, ECO:0000269|PubMed:21247902}.;
Pathway
Validated targets of C-MYC transcriptional repression (Consensus)

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
0.743
rvis_EVS
0.04
rvis_percentile_EVS
57.15

Haploinsufficiency Scores

pHI
0.154
hipred
N
hipred_score
0.480
ghis
0.506

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.192

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ndrg2
Phenotype
integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; skeleton phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;

Gene ontology

Biological process
negative regulation of cytokine production;signal transduction;regulation of vascular endothelial growth factor production;Wnt signaling pathway;substantia nigra development;cell differentiation;negative regulation of smooth muscle cell proliferation;negative regulation of ERK1 and ERK2 cascade;regulation of platelet-derived growth factor production
Cellular component
nucleus;cytoplasm;Golgi apparatus;cytosol;growth cone;perinuclear region of cytoplasm;extracellular exosome
Molecular function
molecular_function;protein binding